Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1973 Aug;14(4):509–514.

Circulating conversion products of C3 in liver disease. Evidence for in vivo activation of the complement system

P Teisberg, E Gjone
PMCID: PMC1553804  PMID: 4201114

Abstract

Circulating conversion products of the third component of human complement (C3) were sought for in different forms of liver disease by the method of antigen–antibody crossed electrophoresis. Immunochemical determinations of C3 and C4 by the single radial immunodiffusion method were performed simultaneously.

The conversion product C3b was found in four out of twelve patients with chronic active hepatitis (CAH) and in seven out of nine with primary biliary cirrhosis (PBC). C3b was also seen in a patient with the special form of acute hepatitis characterized by arthritic prodromas and a high titre of hepatitis-associated antigen (HAA) in serum in the acute phase.

The group of CAH patients had low serum C3 and C4 regardless of whether C3 breakdown products could be demonstrated or not. In PBC normal serum levels of C3 and C4 were generally found.

It is concluded that in some patients with CAH and in a majority of the patients with PBC activation of complement takes place in vivo, possibly on immune complexes deposited in the liver. The serum level of C3 is not a good parameter of immunologic activity in liver disease.

Full text

PDF
509

Images in this article

511Fig. 1
on p.511

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alper C. A., Abramson N., Johnston R. B., Jr, Jandl J. H., Rosen F. S. Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection. J Clin Invest. 1970 Nov;49(11):1975–1985. doi: 10.1172/JCI106417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alper C. A., Johnson A. M. Immunofixation electrophoresis: a technique for the study of protein polymorphism. Vox Sang. 1969 Nov;17(5):445–452. doi: 10.1111/j.1423-0410.1969.tb00414.x. [DOI] [PubMed] [Google Scholar]
  3. Alper C. A., Rosen F. S. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients. J Clin Invest. 1967 Dec;46(12):2021–2034. doi: 10.1172/JCI105691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Alpert E., Isselbacher K. J., Schur P. H. The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies. N Engl J Med. 1971 Jul 22;285(4):185–189. doi: 10.1056/NEJM197107222850401. [DOI] [PubMed] [Google Scholar]
  5. De Groote J., Desmet V. J., Gedigk P., Korb G., Popper H., Poulsen H., Scheuer P. J., Schmid M., Thaler H., Uehlinger E. A classification of chronic hepatitis. Lancet. 1968 Sep 14;2(7568):626–628. doi: 10.1016/s0140-6736(68)90710-1. [DOI] [PubMed] [Google Scholar]
  6. Doniach D. Autoimmune aspects of liver disease. Br Med Bull. 1972 May;28(2):145–148. doi: 10.1093/oxfordjournals.bmb.a070915. [DOI] [PubMed] [Google Scholar]
  7. Dudley F. J., Fox R. A., Sherlock S. Relationship of hepatitis-associated antigen (H.A.A.) to acute and chronic liver injury. Lancet. 1971 Jul 3;2(7714):1–3. doi: 10.1016/s0140-6736(71)90001-8. [DOI] [PubMed] [Google Scholar]
  8. LAURELL C. B. ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS. Anal Biochem. 1965 Feb;10:358–361. doi: 10.1016/0003-2697(65)90278-2. [DOI] [PubMed] [Google Scholar]
  9. LUNDH B. THE EFFECT OF INCUBATION WITH HYDRAZINE AND IMMUNOPRECIPITATE ON BETA-1C-GLOBULIN. Acta Pathol Microbiol Scand. 1965;63:266–274. doi: 10.1111/apm.1965.63.2.266. [DOI] [PubMed] [Google Scholar]
  10. Laurell C. B., Lundh B. Electrophoretic studies of the conversion products of serum beta-1C-globulin. Immunology. 1967 Mar;12(3):313–319. [PMC free article] [PubMed] [Google Scholar]
  11. Lepow I. H., Rosen F. S. Pathways to the complement system. N Engl J Med. 1972 Apr 27;286(17):942–943. doi: 10.1056/NEJM197204272861710. [DOI] [PubMed] [Google Scholar]
  12. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  13. Onion D. K., Crumpacker C. S., Gilliland B. C. Arthritis of hepatitis associated with Australia antigen. Ann Intern Med. 1971 Jul;75(1):29–33. doi: 10.7326/0003-4819-75-1-29. [DOI] [PubMed] [Google Scholar]
  14. Petz L. D., Fink D. J., Letsky E. A., Fudenberg H. H., Müller-Eberhard J. In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia. J Clin Invest. 1969 Nov;47(11):2469–2484. doi: 10.1172/JCI105929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Petz L. D. Variable mechanisms for low serum-complement in liver disease. Lancet. 1971 Nov;2(7732):1033–1034. doi: 10.1016/s0140-6736(71)90347-3. [DOI] [PubMed] [Google Scholar]
  16. Teisberg P. High voltage agarose gel electrophoresis in the study of C 3 polymorphism. Vox Sang. 1970 Jul;19(1):47–56. doi: 10.1111/j.1423-0410.1970.tb01494.x. [DOI] [PubMed] [Google Scholar]
  17. Teisberg P. The conversion rate of human C3 under different storage conditions. Vox Sang. 1971 Mar;20(3):230–238. doi: 10.1111/j.1423-0410.1971.tb00434.x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES